Trigyn Technologies Limited (TRIGYN) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Trigyn Technologies Limited ₹155, price ₹51.80, upside +198.7%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Trigyn Technologies Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range ₹38.65 – ₹211.70 · fair‑value band ₹154.64 – ₹154.80 · the ₹51.80 price screens below the ₹154.73 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 27, 2026.
Follow Trigyn Technologies in your weekly email
Every Wednesday you see whether Trigyn Technologies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Trigyn Technologies Limited provides communications and information technology staffing support services in India and internationally.
Show more
Trigyn Technologies Limited provides communications and information technology staffing support services in India and internationally. The company provides cloud and infrastructure, Medicaid MMIS, SAP, data and artificial intelligence, development and maintenance, digital learning and transformation, smart cities and IoT, vaccination management, and staffing and consulting services, as well as blockchain solutions. It serves BFSI, education, government, healthcare, IGO, and security and surveillance industries. The company was formerly known as Leading Edge Systems Ltd and changed its name to Trigyn Technologies Limited in July 2000. Trigyn Technologies Limited was incorporated in 1986 and is based in Mumbai, India.
Stock analysis
Trigyn Technologies Limited (TRIGYN) currently trades at ₹51.80, while our model-based Fair Value estimate is ₹154.73, implying the stock looks roughly 66.5% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of ₹185.15 per share, and 16 of the 23 models we run sit above the ₹51.80 price.
Bear case: the Multiples group reads lowest at ₹18.07, and 7 of the 23 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹154.64 (bear) to ₹154.80 (bull), the price of ₹51.80 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 60/100 (solid quality), in the Technology sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Trigyn Technologies Limited reported revenue of ₹9.8B in FY2026 versus ₹10.4B in FY2022, a compound −1.6%/yr. Reported net income was ₹19.9M in FY2026, compounding −52.5%/yr from FY2022.
Key figures
Market cap ₹1.6B (≈ $16.4M) · P/E ratio 68.2 · P/S ratio 0.14 · EPS (TTM) ₹0.7600 · Net margin 0.2% · Return on equity 0.3% · Return on assets (EBIT) 3.9% · Operating margin 1.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 39% below its 52-week high and 34% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at 44% fair-value upside, at 199%, TRIGYN screens cheaper than that median.
Fair Value models
Bear ₹154.64Fair Value ₹154.73Bull ₹154.80
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹0.3852 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+8.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−8.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.2%
Start year 2021 (pandemic). Over 10 years: +4.6% a year
Revenue growth 20 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.4%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−47.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year−47.5%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−47.5% vs −25.7%, slowing
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 0%
Start year 2021 (pandemic)
Growth Forecast
Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
Yearly growth needed for the next five years to justify today's price.
Compare Trigyn Technologies Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Information Technology Services · 461 stocks
Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score60 · Above median
Fair Value upside+198.7% · Top 25%
Profitability
Return on equity (TTM)0.3% · Bottom 25%
Return on assets0.0% · Bottom 25%
Net margin (TTM)0.2% · Bottom 25%
Operating margin (TTM)1.1% · Below median
Growth and dividend
Revenue growth4.7% · Below median
Valuation Multiplesvs Information Technology Services median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Trigyn Technologies Limited (TRIGYN) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of ₹154.73 versus a price of ₹51.80, about +199% upside (undervalued).
What is the fair value of TRIGYN?
Our model-based fair value for Trigyn Technologies Limited is ₹154.73 (as of Sep 27, 2026), built from audited fundamentals. The current price: ₹51.80.
What is the quality score of TRIGYN?
Trigyn Technologies Limited has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Trigyn Technologies Limited (TRIGYN)?
Our model-based price target is the fair value of ₹154.73 (as of Sep 27, 2026) from 23 valuation models. Cautious scenario ₹154.64, optimistic scenario ₹154.80. It is a calculation from audited fundamentals, not an analyst target.
What is the Trigyn Technologies Limited stock forecast for 2026?
Our models put fair value at ₹154.73, about +199% upside versus a price of ₹51.80 (undervalued). Cautious scenario ₹154.64, optimistic scenario ₹154.80. The calculation is refreshed regularly with new filings.
What is the revenue of Trigyn Technologies Limited (TRIGYN)?
Trigyn Technologies Limited reported trailing-twelve-month revenue of about ₹9.8B (latest available figure, as of Sep 27, 2026).
What growth is priced into Trigyn Technologies Limited (TRIGYN)?
For today's price to be fair in a discounted-cash-flow model, Trigyn Technologies Limited would have to grow free cash flow by less than minus 40 % per year for five years (discount rate 11.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -0.2 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of TRIGYN use?
Our models discount Trigyn Technologies Limited at 11.5 %: a base by market capitalisation (nano), damped by beta 0.73, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Trigyn Technologies Limited that is less than minus 40 % per year a year over ten years, using the same discount rate (11.5 %) and the same formula as our fair value.
How much growth has Trigyn Technologies Limited (TRIGYN) delivered so far?
Over the past 5 years revenue at Trigyn Technologies Limited grew -0.2 % a year. The price currently implies less than minus 40 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Trigyn Technologies Limited (TRIGYN) growing?
The median revenue growth in the sector is +9.6 % a year. That is the yardstick for the growth priced into Trigyn Technologies Limited (less than minus 40 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Trigyn Technologies Limited (TRIGYN)?
The free-cash-flow yield on the price is 2.52 %: that much free cash flow Trigyn Technologies Limited produces per unit of market value. When it exceeds the discount rate of our models (11.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Trigyn Technologies Limited (TRIGYN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Trigyn Technologies Limited it is ₹154.73 per share (as of Sep 27, 2026), against a price of ₹51.80. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Trigyn Technologies Limited stock overvalued or undervalued in 2026?
As of Sep 27, 2026, TRIGYN trades below its calculated fair value: price ₹51.80, fair value ₹154.73, a gap of about +199% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TRIGYN?
No. The price is what the market pays today (₹51.80); the fair value is what the company's own numbers justify (₹154.73). For Trigyn Technologies Limited the two are ₹102.93 per share apart. That gap is exactly why we show both numbers side by side.
How much is Trigyn Technologies Limited worth?
The market values Trigyn Technologies Limited at about ₹1.6B (market capitalisation, as of Sep 27, 2026). Per share that is ₹51.80; our models calculate a fair value of ₹154.73 per share.
What do the bullish and bearish scenarios say about TRIGYN?
Our models span a range for Trigyn Technologies Limited: cautious scenario ₹154.64, base ₹154.73, optimistic ₹154.80 per share (as of Sep 27, 2026, price ₹51.80). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of TRIGYN?
Trigyn Technologies Limited trades at a price-to-earnings ratio of 68.2 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹154.73 is built from several models across several years. Other multiples: P/B 0.2, P/S 0.2.
How solid is the balance sheet of Trigyn Technologies Limited (TRIGYN)?
Balance-sheet figures for Trigyn Technologies Limited (as of Sep 27, 2026): return on equity 0.3%. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is TRIGYN from its 52-week high?
Trigyn Technologies Limited trades at ₹51.80, about 39% below its 52-week high of ₹84.42 and 34% above the low of ₹38.65 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹154.73 is for.
Which stocks are comparable to Trigyn Technologies Limited?
From the same area (Technology) we also value International Business Machines Corporation, Accenture plc, Tata Consultancy Services Limited, Infosys Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Trigyn Technologies Limited stock attractive at the current price?
The data as of Sep 27, 2026: price ₹51.80, calculated fair value ₹154.73 (+199%), Quality Score 60/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of TRIGYN calculated?
We run Trigyn Technologies Limited through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹154.73, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Trigyn Technologies Limited currently trades 67 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Trigyn Technologies Limited (TRIGYN)?
The closing price on Oct 1, 2026 was ₹51.80. Our model-based fair value is ₹154.73, about +199% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Trigyn Technologies Limited right now?
The price is below even our cautious bear case (₹154.64). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (60/100) at a price below fair value, the discount is the argument here, not the business quality. The models converge in a tight band (₹154.64 to ₹154.80), unusually little disagreement for a valuation.
Where does the earnings growth of Trigyn Technologies Limited (TRIGYN) come from?
Earnings per share at Trigyn Technologies Limited grew −11.7 % a year from 2015 to 2026. Broken into its drivers: revenue per share +6.3 %, EBIT margin −19.4 %, tax rate −3.6 %, residual (interest, one-offs) +6.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Trigyn Technologies Limited
How large is the market capitalisation of Trigyn Technologies Limited (TRIGYN)?
The market capitalisation of Trigyn Technologies Limited is ₹1.6B (≈ $16.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Trigyn Technologies Limited (TRIGYN)?
The price-to-sales ratio of Trigyn Technologies Limited is 0.14 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Trigyn Technologies Limited (TRIGYN)?
Earnings per share at Trigyn Technologies Limited are ₹0.7600 (price ÷ EPS = P/E 68.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Trigyn Technologies Limited (TRIGYN)?
The net margin of Trigyn Technologies Limited is 0.2% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Trigyn Technologies Limited (TRIGYN)?
The return on equity (ROE) of Trigyn Technologies Limited is 0.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Trigyn Technologies Limited (TRIGYN)?
On an EBIT basis the return on assets of Trigyn Technologies Limited is 3.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Trigyn Technologies Limited (TRIGYN)?
The operating margin of Trigyn Technologies Limited is 1.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Trigyn Technologies Limited (TRIGYN)?
Revenue at Trigyn Technologies Limited is growing +4.7% versus a year earlier (3y avg −8.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Trigyn Technologies Limited (TRIGYN)?
Earnings per share at Trigyn Technologies Limited are growing −74.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Trigyn Technologies Limited (TRIGYN) hold?
Trigyn Technologies Limited holds more cash than debt, ₹4.6B net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Trigyn Technologies Limited in the live analysis
One click puts Trigyn Technologies Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
